We are concerned with testing replicability hypotheses for many endpoints simultaneously. This constitutes a multiple test problem with composite null hypotheses. Traditional p-values, which are computed under least favourable parameter configurations, are over-conservative in the case of composite null hypotheses. As demonstrated in prior work, this poses severe challenges in the multiple testing context, especially when one goal of the statistical analysis is to estimate the proportion π 0 of true null hypotheses. Randomized p-values have been proposed to remedy this issue. In the present work, we discuss the application of randomized p-values in replicability analysis. In particular, we introduce a general class of statistical models for which valid, randomized p-values can be calculated easily. By means of computer simulations, we demonstrate that their usage typically leads to a much more accurate estimation of π 0 . Finally, we apply our proposed methodology to real data from genomics.
Introduction
The replication of scientific results is essential for their acceptance by the scientific community. In order to judge whether a scientific result has been replicated in an independent study, appropriate scientific methods are needed. We are concerned with developing such methods by formalizing the replication as a statistical hypothesis which has to be tested with an appropriate procedure. In particular, a simultaneous replicability analysis for many endpoints or markers, respectively, requires specialized multiple test procedures. We propose the usage of randomized p-values, as introduced by Dickhaus (2013) , in this context.
For a single hypothesis test based on a test statistic T (X), where X is the observable random variable, mathematically representing the data set, a (non-randomized) p-value p(X) is a (deterministic) transformation of T (X) onto [0, 1] . Small values of p(X) indicate incompatibility of the observed data with the null hypothesis H of interest. When basing test decisions on the p-value, type I error control at any pre-defined significance level α ∈ (0, 1) is then equivalent to pr ϑ {p(X) ≤ α} ≤ α, α ∈ (0, 1), ϑ ∈ H,
where pr ϑ denotes the probability measure under the parameter ϑ of the statistical model under consideration. A p-value fulfilling (1) is called a valid p-value.
In case of composite null hypotheses H, p-values are required to fulfill condition (1) under all parameter values ϑ 0 ∈ H. Hence, it is of interest to determine parameter values in H which maximize the probability in (1) . These are called least favourable parameter configurations (LFCs) . Under continuity assumptions, the p-value will usually be uniformly distributed under LFCs. However, if ϑ ∈ H is not an LFC, we typically have a strict inequality in condition (1) for many values of α ∈ [0, 1].
In the context of simultaneous testing of multiple null hypotheses, this deviation from the uniform distribution is problematic when utilizing dataadaptive multiple tests that rely on a pre-estimation of the proportion π 0 of the true null hypotheses. Non-uniformity can for example be caused by the presence of composite null hypotheses, as described before, or by the discreteness of the model. Randomized p-values resulting from a data-dependent mixing of the original p-value and an additional on [0, 1] uniformly distributed random variable U, that is stochastically independent of the data X, are then often considered in the literature. The distribution of the randomized p-values under the null is typically much closer to uniformity than that of the non-randomized ones. In case of discrete models randomized p-values for simple null hypotheses H = {ϑ * } have been discussed, among others, by Finner and Strassburger (2007) ; Habiger and Peña (2011) ; Dickhaus et al. (2012) ; Habiger (2015) . These randomized p-values are closely related to well-known randomized hypothesis tests in discrete models, and they are exactly uniformly distributed under ϑ * . For composite null hypotheses H, even in non-discrete models, it is not possible to achieve exact uniformity without abandoning the data completely. Dickhaus (2013) proposed one set of datadependent weights for the mixing of X and U, that works well for composite, one-sided null hypotheses at least in certain location parameter models.
Due to irreproducibility, randomized p-values are not suitable for the final decision making. However, as demonstrated by Dickhaus et al. (2012) , Dickhaus (2013) and others, they are very useful in the context of estimation the proportion π 0 of true null hypotheses. One popular estimator for π 0 has been proposed by Schweder and Spjøtvoll (1982) . We will denote this estimator byπ 0 ≡π 0 (λ), where λ ∈ [0, 1) is a tuning parameter, and will refer toπ 0 as the Schweder-Spjtvoll estimator. The proposal is to utilize randomized p-values inπ 0 . Since validity of the p-values utilized inπ 0 is essential for the performance of the Schweder-Spjtvoll estimator, we will provide some sufficient conditions for the validity of randomized p-values in the sequel.
We will be particularly interested in replicability analysis, where one aims at identifying discoveries made across more than one of s ≥ 2 given independent studies. The null hypothesis of no replication is a special type of a composite null hypothesis. While a typical meta-analysis (see, e. g., Kulinskaya et al. (2008) ) pools the available data across the studies, replicability analysis requires findings to hold in at least γ studies, where 2 ≤ γ ≤ s is a pre-defined parameter. This is an important distinction, since in a metaanalysis, one extremely small p-value may suffice to produce a small combined p-value, regardless of the evidence contributed by the other studies. Instead of combining all (endpoint-specific) p-values from the s studies, replicability analysis will usually apply a combination of all but the γ −1 smallest of these p-values. In the context of bio-marker identification we consider s ≥ 2 independent studies that examine m ≥ 2 endpoints as possible bio-markers for a given disease. Whether one endpoint constitutes a bio-marker may differ between the studies, since the latter are (usually) conducted under different settings like different (sub-)populations. It is of interest to find bio-markers that are associated with the disease in at least γ different settings to rule out findings that can only be ascribed to one specific study setup. With our proposed methodology, it is possible to accurately estimate the number of replicated bio-markers. This is of interest in itself, but can also be used to increase the power of a multiple test for replicability. More details are provided in Sections 4 and 5.
Simultaneous testing of multiple replicability statements has also been the focus in prior literature. Benjamini et al. (2009) made use of partial conjunction nulls, meaning that at least a pre-specified number of the (study-specific) null hypotheses for a given endpoint are true, see also Benjamini and Heller (2008) . They propose combining the s − γ + 1 largest p-values for each endpoint in an appropriate manner, and then using an FDR controlling procedure on these partial conjunction p-values. Bogomolov and Heller (2013) presented algorithms that separate s = 2 studies into primary and follow-up study. An empirical Bayesian approach has been proposed by Heller and Yekutieli (2014) . introduced the r-value for each hypothesis, which indicates the lowest significance level with respect to the false discovery rate (Benjamini and Hochberg, 1995) at which the corresponding hypothesis can be rejected. This allows for a ranking among the examined features. Bogomolov and Heller (2018) proposed to first select the promising features from each study separately and then to test the selected features.
Model setup
In the following, we introduce a general model for which randomized p-values are easily computable. The parameter s is the number of studies, and the parameter m ≥ 2 is the number of endpoints (potential biomarkers) which also equals the number of null hypotheses. In the examples in Sections 2 and 3 we only consider the case of s = 1, which can be interpreted as bio-marker identification without replicability requirements. In Section 4, where we introduce replicability analysis, we only consider s ≥ 2.
Consider a statistical model (Ω, F , (pr ϑ ) ϑ∈Θ ) and let θ = (θ 1 , . . . , θ m ) :
where R denotes the set of real numbers. We assume that consistent and, at least asymptotically, unbiased estimatorŝ θ j = (θ 1,j , . . . ,θ s,j ) : Ω → R s , for θ j (ϑ) = (θ 1,j (ϑ), . . . , θ s,j (ϑ)) are available (j = 1, . . . , m).
We consider m null hypotheses and their corresponding alternatives given by θ j (ϑ) ∈ H j versus θ j (ϑ) ∈ K j = Θ ′ j \ H j , where H j and K j are non-empty subsets of Θ ′ j and Borel sets of R s (j = 1, . . . , m).
Furthermore, we assume that marginal tests ϕ j for testing H j against K j are constructed as ϕ j (x) = 1{T j (x) ∈ Γ j (α)}, where Γ j (α) denotes a rejection region, α ∈ (0, 1) denotes a fixed, local significance level, x ∈ Ω an observation, and T j : Ω → R a measurable mapping such that the test statistic T j (X) has a continuous cumulative distribution function under any ϑ ∈ Θ (j = 1, . . . , m). We often writeθ j or T j instead ofθ j (X) and T j (X), respectively (j = 1, . . . , m).
The following general assumptions are made:
(GA2) Nested rejection regions: for every j = 1, . . . , m and α ′ < α, it holds Γ j (α ′ ) ⊆ Γ j (α).
(GA3) For every j = 1, . . . , m and α ∈ (0, 1), it holds sup
(GA4) For every j = 1, . . . , m, the set of least favourable parameter configurations (LFCs) for ϕ j , i.e. the set of parameters that yield the supremum in (GA3), does not depend on α.
The conditions (GA2) − (GA4) are the same as required for the models in Dickhaus (2013) , whereas for assumption (GA1) in Dickhaus (2013) only the condition {x ∈ Ω : T j (x) ∈ Γ j (α)} ⊆ {x ∈ Ω :θ j (x) ∈ K j } for α small enough has to be met. Assumption (GA1) serves as a connection between the statistics T j (X) andθ j (X). It requires, that {θ j ∈ K j } is in itself a rejection event at level c j . Furthermore, assumption (GA2) together with (GA1) implies
for all x ∈ Ω (j = 1, . . . , m). Assumption (GA3) means that under any LFC for ϕ j the rejection probability is exactly α. LFC-based p-values for the marginal tests ϕ j are formally defined as
Under assumptions (GA2) -(GA4), we obtain
Such LFC-based p-values p LF C j (X) are uniformly distributed on [0, 1] under any LFC for ϕ j (Lehmann and Romano, 2005, Lemma 3.3.1) . For any t ∈ [0, 1] and x ∈ Ω, the relation
holds true (j = 1, . . . , m), which will be useful later on. Example 1. Models 1 and 2 in Dickhaus (2013) are one-sided normal means models that fulfill the general assumptions (GA1) -(GA4). Note that the indices i in Dickhaus (2013) correspond to the indices j in our notation, and that the dimension s of the derived parameters is one in both models. Dickhaus (2013) showed that the general assumptions (GA2) -(GA4) hold. Our stricter assumption (GA1) follows from the fact that the estimatorŝ θ j (X) are positive, i.e. inside the alternative, if and only if the test statistics T j (X) are positive, such that c j = 1/2 (j = 1, . . . , m) due to symmetry.
The randomized p-values

General properties
Let U 1 , . . . , U m be stochastically independent and identically, uniformly distributed on [0, 1], such that each U j is stochastically independent of X. We obtain randomized p-values p rand j by mixing U j and p LF C j in a data-dependent manner, specifically
where G j is a suitable function necessary for the validity of the randomized p-values and 0 ≤ w j (x) ≤ 1 are data-dependent weights (j = 1, . . . , m).
We consider the choice w j (X) = 1 H j {θ j (X)} (j = 1, . . . , m), which follows the definition of randomized p-values as introduced in Dickhaus (2013).
Definition 1.
We define randomized p-values as follows
where G j denotes the conditional cumulative distribution function of p LF C j (X) given the event {θ j ∈ K j } under any LFC for ϕ j (j = 1, . . . , m).
Ideally, we want p-values to be uniformly distributed on [0, 1] under null hypotheses. For a fixed j = 1, . . . , m, we therefore set p rand j (X) = U j if θ j (X) ∈ H j holds. Due to (2) , ϕ j (x) = 0 wheneverθ j (x) ∈ H j holds, when applying a local significance level α < c j . This means, that in that case we cannot reject H j at a significance level lower than c j . Since c j can be very large, e. g. 1/2 in Example 1 and even larger in our models for replicability analysis in Section 4, we can, in practice, assume that H j is true in case ofθ j (X) ∈ H j , and switch to a uniform variate U j that has the desired properties for a p-value under H j .
In the following theorem we give formulas for the calculation of the function G j and the randomized p-value p rand j (j = 1, . . . , m).
Theorem 1.
Let j ∈ {1, . . . , m} be fixed and ϑ 0 ∈ Θ with θ j (ϑ 0 ) ∈ H j be any LFC for ϕ j . Under assumptions (GA1) -(GA4) we obtain the following.
It holds
The randomized p-values, as defined in Definition 1, are of the form
for any x ∈ Ω and u j ∈ [0, 1], when disregarding the case p LF C j (x) = c j , for which p rand j (x, u j ) is either 1 or u j (j = 1, . . . , m). Example 2. We apply Theorem 1 to both models in Example 1. In both models it holds, that
2. (Multiple t-tests model) Analogously to the multiple Z-tests model, it follows c j = 1/2 and
directly from Theorem 1.
These results agree with the calculations in (Dickhaus, 2013 (Dickhaus, , pp.1971 (Dickhaus, , 1973 ).
Conditions for the validity of the randomized p-values
As mentioned before, valid p-values are usually required for a conservative estimation of the proportion π 0 of true null hypotheses if the Schweder-Spjøtvoll estimatorπ 0 is applied. This section provides some conditions for the validity of the randomized p-values as defined in Definition 1 for our model setup.
Theorem 2.
Let j ∈ {1, . . . , m} be fixed. Under the general assumptions (GA1) -(GA4), assume that p LF C j (X) has a continuous and strictly increasing cumulative distribution function under any ϑ ∈ Θ. Then, the randomized p-value p rand j , as defined in Definition 1, is a valid p-value if and only if
for any ϑ ∈ Θ with θ j (ϑ) ∈ H j and for any LFC ϑ 0 for ϕ j .
The following results in the rest of this section give alternative conditions for the validity of the randomized p-values p rand j .
Then, for all ϑ ∈ Θ with θ j (ϑ) ∈ H j , it holds h ϑ (0) = h ϑ (1) = 0.
Proof. We see that h ϑ (0) = pr ϑ T j (X) ∈ Γ j (0) = 0. Due to assumption (GA1) and Theorem 1 it holds
The condition h ϑ ≤ 0 for all ϑ with θ j (ϑ) ∈ H j , is equivalent to the condition in Theorem 2, and hence equivalent to the validity of p rand j . With Lemma 1 the convexity of h ϑ for all ϑ ∈ Θ with θ j (ϑ) ∈ H j would also be sufficient for the validity of p rand j . In many applications, a rejection of H j after observing T j (x) implies a rejection of H j if we observe larger test values T j (y) ≥ T j (x), x, y ∈ Ω. More specifically, the rejection regions are often of the form Γ
under an LFC for ϕ j , such that (GA3) holds. Among others, the models from Example 1, fulfill this condition, under which the validity of the randomized p-value p rand j follows from T j (X) being smaller in the hazard rate order under any ϑ ∈ Θ with θ j (ϑ) ∈ H j than under an LFC for ϕ j .
We denote the hazard rate order and the likelihood ratio order with " ≤ hr " and " ≤ lr ", respectively. For a brief introduction to our notations we refer to the appendix. Theorem 3. Let a model as in Section 2 be given and j = 1, . . . , m be fixed. We formulate the following condition: The rejection regions are of the form Shaked and Shanthikumar (2007) , replacing the hazard rate order by the likelihood ratio order in Theorem 3 is also sufficient for the validity of p rand j . Example 3. We show via Theorem 3 that the randomized p-values as calculated in Example 2 are valid. Let j ∈ {1, . . . , m} be fixed.
Recall that T j (X) =X j is normally distributed on R with variance 1/n j and expected values µ j and 0 under ϑ and ϑ 0 , respectively. It is easy to show that f ϑ 0 (t)/f ϑ (t) is nondecreasing in t and therefore T j (X) (ϑ) ≤ lr T j (X) (ϑ 0 ) holds. According to Corollary 1, the randomized p-value p rand j is valid.
(Multiple t-tests
Model) Now we have that T j (X) = n 1/2 jX j /S j possesses a non-central t-distribution with non-centrality parameter τ j (ϑ) and n j −1 degrees of freedom, τ j (ϑ) = n 1/2 j µ j /σ j , and µ j = θ j (ϑ). According to (Karlin and Rubin, 1956, p. 639) and (Karlin, 1956, p. 126 
. According to Corollary 1, the randomized p-value p rand j , in this model is indeed valid.
Randomized p-values in replicability analysis
Model setup
We come back to the framework of bio-marker identification. We want to find bio-markers that have been verified in at least γ studies, where the parameter γ ∈ {2, . . . , s} is pre-defined and fixed. For γ = s, we declare discoveries replicated, only if they have been made in each considered study. Also, it is clear, that the set of false null hypotheses is non-increasing in γ.
For each endpoint j and study i, we denote the true effect on the considered disease state by a parameter θ i,j , where θ i,j > 0 mean positive effects. We consider an endpoint a bio-marker only if it exhibits a positive effect on the disease. This can be replaced by testing for any one fixed, directional association between the endpoint and the disease. The parameters θ i,j may differ inherently in i due to the different settings across the studies like different populations or different laboratory / statistical methods. We consider the model from Section 2 for s ≥ 2. Unless stated otherwise, we only consider Θ ′ = R sm , i.e. each derived parameter θ i,j may take any value in R (i = 1, . . . , s; j = 1, . . . , m).
Before we get to constructing the test statistics T j (X) and the rejection regions Γ j (α), we first make some requirements about the marginal model setup. This will make it easier to present sufficient conditions for the general assumptions (GA1) -(GA4) from Section 2. We do not require the data for different endpoints in the same study to be independent.
For every study i = 1, . . . , s and marker j = 1, . . . , m we test for a positive effect size of endpoint j with regard to the disease,
We assume that a consistent and, at least asymptotically, unbiased estimatorθ i,j : Ω → R for θ i,j (ϑ) is available. Furthermore, the marginal test ϕ i,j for testing H i,j against K i,j is based on a test statistic T i,j (X) and rejection regions Γ i,j (α), where α ∈ (0, 1) denotes the (local) significance level, x ∈ Ω an observation, and T i,j : Ω → R a measurable mapping such that the test statistic T i,j (X) has a continuous distribution under any ϑ ∈ Θ. The corresponding LFC-based p-values are then denoted by p i,j (X).
For every i = 1, . . . , s and j = 1, . . . , m we make the following assumptions:
(RA2) The assumptions (GA1)−(GA4) are fulfilled. We denote with c i,j the value, that satisfies {x ∈ Ω :
(RA3) The p-value p i,j (X) is an antitone transformation of the test statistic T i,j (X), and there exists a d j ∈ (0, 1) such that p i,j (x) < d j ⇔θ i,j (x) > 0, for all x ∈ Ω.
(RA4) It holds lim
In one-sided problems, assumption (RA1) is usually fulfilled. Due to (RA1) it now holds
compared to (3) . Assumption (RA3) is akin to assumption (GA1) from Section 2, and follows from (RA2) if and only if d j = c 1,j = · · · = c s,j holds (j = 1, . . . , m).
For convenience we write
where ϑ 1 is such, that θ i,j (ϑ 1 ) = ∞, although ϑ 1 is technically not a parameter. Assumption (RA4) is equivalent to p i,j (X) = 0 almost surely under any such ϑ 1 (i = 1, . . . , s; j = 1, . . . , m).
For a given fixed γ ∈ {2, . . . , s} we define replicability as the presence of a positive effect size in at least γ out of the s studies. Let H 1 , . . . , H m be the non-replicability null hypotheses and K 1 , . . . , K m be the respective alternative hypotheses. Formally, we define
for j = 1, . . . , m. Furthermore, we define consistent and, at least asymptotically, unbiased estimators for
To make a decision about the replicability of an effect for marker j we consider the ordered p-values p (1),j < · · · < p (s),j for the hypotheses H i,j (i = 1, . . . , s), in the s studies. One plausible approach is to look at the γ smallest p-values and reject H j if these are all below a suitable threshold. We define
Let G j be the conditional cumulative distribution function of p LF C j (X) givenθ j (X) ∈ K j under any LFC ϑ 0 ∈ Θ for ϕ j , cf. Definition 1. For the derivation of c j = 1 − (1 − d j ) n−γ+1 , we refer to the proof of Lemma 2 in Appendix C. According to Theorem 1 it holds Example 4. In the following, we consider models, in which we utilize either a Z-test or a t-test for each study i and endpoint j.
Model 1: In each study i = 1, . . . , s we consider a multiple Z-tests model.
For fixed sample sizes n i,j , (i = 1, . . . , s; j = 1, . . . , m), we consider the observations
For each study i and marker j the observations X
As before, we test the null hypotheses H i,j = {µ i,j ≤ 0} against the alternatives K i,j = {µ i,j > 0}. A consistent and unbiased estimator for
, which is normally distributed on R with expected value µ i,j and variance 1/n i,j .
Furthermore, we choose test statistics T i,j (X) =θ i,j (X) and rejection
is the cumulative distribution function of the normal distribution on R with expected value µ and variance σ 2 .
Assumptions (RA1) -(RA3) have already been discussed before, with c i,j = d j = 1/2 for all i, j, and (RA4) is clear. Under this model, due to Lemma 2, assumptions (GA1) -(GA4) are fulfilled.
are analogous to verify, which again results in an overall model that fulfills assumptions (GA1) -(GA4).
We give a sufficient condition based on Theorem 3 for the validity of the randomized p-values p rand j , that result from our model setup.
Theorem 4. Let a model be given, such that assumptions (RA1) -(RA4) are fulfilled, and let j ∈ {1, . . . , m} be fixed.
If, for all i = 1, . . . , s and ϑ,
For a model that fulfills Theorem 4 the randomized p-values p rand i,j (i = 1, . . . , s), resulting from study i and marker j, would be, as a result of Theorem 3, valid as well.
Example 5. The randomized p-values p rand j (j = 1, . . . , m), in Models 1 and 2, as introduced in Example 4 are valid. We show that for Model 1.
Recall that T i,j (X) =θ i,j (X) is normally distributed on R with expected value θ i,j (ϑ) and variance 1/n i,j under ϑ ∈ Θ, where n i,j (i = 1, . . . , s; j = 1, . . . , m), are the fixed sample sizes. For i ∈ {1, . . . , s} and ϑ, ϑ
It follows from Theorem 4 and Theorem 1.C.2 in Shaked and Shanthikumar (2007) , that p rand j is a valid p-value (j = 1, . . . , m). In Fig. 1 we compare the cumulative distribution functions of (p LF C j ) j and (p rand j ) j for θ j (ϑ) ∈ H j ,θ j (ϑ) = (−1.5 n −1/2 1,j , . . . , −1.5 n −1/2 s−γ+1,j , 1, . . . , 1), and θ j (ϑ) ∈ K j , θ j (ϑ) = (2 n −1/2 1,j , . . . , 2 n −1/2 s,j ), in the first and second graph, respectively, where we set s = 10, γ = 6, and the sample sizes to n 1,j = · · · = n s,j = 50.
The left graph shows that the randomized p-value p rand j (X, U) is stochastically not larger than the LFC-based p-value p LF C j (X) but remains valid, i.e. not smaller than a uniform distribution on [0, 1]. It is apparent that p rand j (X, U) comes much closer to the uniform distribution on [0, 1]. The right graph, however, illustrates how the randomized p-value p rand j (X, U) is stochastically larger than the LFC-based p-value p LF C j (X), under a parameter ϑ ∈ Θ with θ j (ϑ) ∈ K j .
Estimation of the proportion of true null hypotheses
Motivation
In this section we demonstrate how randomized p-values generally lead to a more precise estimation of the proportion π 0 of true null hypotheses. This is useful for data-adaptive multiple test procedures, but knowing m 0 = m · π 0 can also be valuable in itself. In bio-marker identification, for instance, the (Schweder and Spjøtvoll, 1982) . The estimatorπ 0 (λ) represents the proportion of p-values above λ divided by the expected proportion of the latter given uniformly distributed p-values. Assuming that the p-values corresponding to the false null hypotheses are always below λ, and the ones corresponding to the true null hypotheses are uniformly distributed on [0, 1], the term 1 −F m (λ) is then, in expectation equal to (1 − λ)π 0 , leading to an unbiased estimatorπ 0 (λ) for π 0 . Graphically, the estimatorπ 0 (λ) equals one minus the offset at t = 0 of the straight line connecting (λ,F m (λ)) with (1, 1) . We sometimes writeπ LF C 0 or π rand 0 to emphasize the usage of the LFC-based or the randomized p-values in the estimatorπ 0 , respectively.
Simulations
First, we simulated one realization of the empirical cumulative distribution functions of (p LF C j ) j=1,...,m and (p rand j ) j=1,...,m , computed on the same data, where we chose m = 500, s = 10, γ = 6, and π 0 = 0.7. Hence, we (1, 1) and (0, 1 − π 0 ). The two thinner, straight lines connect the points (1, 1) and (λ,F m (λ)) and intersect the vertical axis at (0, 1 −π rand 0 (λ)) or (0, 1 −π LF C 0 (λ)) for the respective p-values.
consider 10 studies, each examining the same 500 endpoints, where m 1 = 150 of these have a positive effect in at least γ = 6 and the other m 0 = 350 have a positive effect in less than 6 studies. We call these true and false endpoints, respectively, according to whether their respective null hypotheses are true or false. For each true and false endpoint we drew the number of studies with positive effects binomially from {0, . . . , γ − 1} and {γ, . . . , s} with the same success probabilities p 0 = 0.8 and p 1 = 0.8, respectively. For each study i and endpoint j we set the sample size to n i,j = 50 and drew for non-positive effects θ i,j (ϑ) uniformly from (µ min 50 −1/2 , 0] and for positive effects uniformly from (0, µ max ], where we chose µ min = −2.5 and µ max = 1.5. is closer to the thick line connecting (0, 1 − π 0 ) with (1, 1) . Clearly,π rand 0 (λ) is more accurate thanπ LF C 0 (λ) for 0.1 < λ < 1. Also,π rand 0 (λ) is more stable with respect to λ, as the lower curvature of the respective empirical cumulative distribution function indicates.
Furthermore, we calculated the expected values ofπ LF C 0 (λ) andπ rand 0 (λ) for different values of π 0 , (µ min , µ max ), and γ, where we set s = 10, m = 100, and λ = 1/2. Apart from that, we drew everything else as before.
We looked at each combination of π 0 ∈ {0.6, 0.7, 0.8, 0.9}, (µ min , µ max ) ∈ {(0, 2), (−0.5, 3), (−1, 4), (−1.5, 5)}, and γ ∈ {2, 4, 6, 10}. Each pair (µ min , µ max ) was chosen such that |µ min | and µ max increase simultaneously, and thus, model uncertainty increases in both directions. Figure 3 illustrates the effect γ has on the expected value ofπ 0 (1/2) in each setting when utilizing LFCbased p-values (crosses) or randomized p-values (circles), respectively. For the exact numbers we refer to Table 1 and Table 2 , respectively. All values have been double-checked by Monte-Carlo simulations.
According to Lemma 1 in Dickhaus et al. (2012) , the Schweder-Spjtvoll estimatorπ 0 (λ) applied to either of the p-values has a non-negative bias. This is generally true when utilizing valid, marginal p-values. In each setting we observe lower expected values forπ rand 0 (1/2) than forπ LF C 0 (1/2). The difference between the expectations tend to be more emphasized for higher γ and higher model uncertainty, i.e. for larger µ max and |µ min |.
As mentioned before, we expect a more stable estimationπ 0 (λ) of π 0 with respect to λ when utilizing the randomized p-values. For the parameter settings π 0 = 0.6, γ = 8, µ min = −2, and µ max = 4, Fig. 4 compares the expected values ofπ 0 (λ) for λ = 0.1, 0.2, . . . , 0.9 and either p-values. We checked many other configurations, too. They lead to similar results, although not always so pronounced.
Finally, we examined the higher variance ofπ rand 0 (1/2) when utilizing the randomized p-values (p rand j ) j , due to the additional randomization by U j (j = 1, . . . , m). We calculated the standard deviation ofπ 0 (1/2) utilizing either the LFC-based p-values or the randomized p-values, for the same settings as we did for Fig. 3 via Monte-Carlo simulations. For the results we refer to the appendix. Using (p rand j ) j=1,...,m , we observe higher standard deviations of π rand 0 (1/2) in each setting short of one. The largest standard deviation when using the randomized p-values across all considered settings was just below 0.1. For the exact values we refer to Appendix A. We also compared the mean squared errors ofπ rand 0 andπ LF C 0 in all considered parameter settings. In each setting the mean squared error was higher when using the LFC-based p-values.
An application on multiple Crohn's disease genome-wide assocation studies
We looked at the data from multiple genome-wide association studies with the goal of identifying susceptibility loci for Crohn's disease (Franke et al., 2010) . The authors looked at six distinct genome-wide association studies, further dividing two of these resulting in a total of eight studies, which comprised 6, 333 disease cases and 15, 056 healthy controls altogether. In their discovery panel, they combined these eight studies in a meta-analysis and looked at the most promising features in a further replication panel. For lack Figure 4 : The expected values ofπ 0 (λ) for different tuning parameters λ under Model 1 for m = 100, s = 10, n i,j = 50, γ = 8, π 0 = 0.6, µ min = −2, µ max = 4, and p 0 = p 1 = 0.8 when using either the LFC-based p-values (crosses) or the randomized p-values (circles). of data on the latter part we only looked at the data stemming from the original eight studies.
In their work, the authors applied multiple Z-tests for the logarithmic odds ratios in each scan and combined them to test for two-sided associations of phenotype and genotype at each of m loci. For these, randomized p-values can also be defined (Dickhaus, 2013) . However, in such a two-sided setting each parameter in the null hypotheses H j = {(θ 1,j , . . . , θ s,j ) ∈ R s : θ k,j = 0 for at least s − γ + 1 indices k} (j = 1, . . . , m), would lie next to the respective alternative K j = R s \H j making each one an LFC for their respective null hypothesis. In spite of the composite nature of the null hypotheses, the LFC-based p-values would then hold a uniform distribution under any parameter in the null hypothesis and using randomized p-values would be unnecessary.
Instead, we looked at the original Z-scores for associations in one fixed direction between the investigated single-nucleotide polymorphisms and Crohn's disease. Each of the eight studies investigated the effect of 953, 241 singlenucleotide polymorphisms on Crohn's disease. We designated one of the studies as a primary study and selected the most promising features with the Benjamini-Hochberg step-up procedure at false discovery rate levels q = 0.2 or q = 0.5 (Benjamini and Hochberg, 1995) , respectively. After selection we ended up with m = 630 or m = 2, 257 single-nucleotide polymorphisms, respectively, and tested their associations' replicability based on the remaining s = 7 studies. For both false discovery rate levels q, we looked at the choices γ = 2 and γ = 4, and calculated the LFC-based and randomized p-values as in the model described in Section 4.1. For these values of γ, we have c j = 2 −(7−2+1) = 2 −6 and c j = 2 −(7−4+1) = 2 −4 , respectively, where d j = 1/2 results from the model (j = 1, . . . , m).
We then calculated the Schweder-Spjøtvoll estimatorπ 0 (λ) with λ = 1/2 for the four parameter settings. Figure 5 illustrates the empirical cumulative distribution functions of the LFC-based and the randomized pvalues, respectively, after selection. The values for the settings (q, γ) = (0.2, 2), (0.2, 4), (0.5, 2), (0.5, 4) are, in order, (π LF C 0 (λ), E{π rand 0 (λ)}) = (0.4603, 0.4651), (0.8857, 0.7572), (0.9880, 0.9668), (1.5498, 1.3013 ).
These are also displayed above their corresponding graphs. The standard deviation for the estimation using the randomized p-values are var 1/2 {π rand 0 (λ)} = 0.00276, 0.01542, 0.00377, 0.01109 for the respective settings in the same order. The values corresponding to the use of the randomized p-values are a result of Monte-Carlo simulations with 100, 000 repetitions in each setting. An increase in the false discovery rate level q increases the proportion π 0 which favours the use of the randomized p-values. A higher γ increases the proportion π 0 and reduces the constant c j = 2 −(7−γ+1) (j = 1, . . . , m), both benefiting the estimatorπ rand 0 (λ). Choosing q and γ both too high can lead to a too large π 0 making it difficult to estimate the latter as the example with q = 0.5 and γ = 4 shows. On the other hand, choosing both q and γ too low results in a low proportion of true null hypotheses, of which the remaining do not offer high enough deviation from the alternative to facilitate the usage of randomized p-values as the example with q = 0.2 and γ = 2 shows. Figure 5 : The empirical cumulative distribution functions of the LFC-based and the randomized p-values, respectively, in the multiple Crohn's disease genome-wide associations studies example after selection. Selection has been conducted with the Benjamini-Hochberg step-up procedure with false discovery rates q = 0.2, 0.5, and the p-values are calculated according to the model as described in Section 4 with γ = 2, 4. The straight lines connect the points (1, 1) and (λ,F m (λ)), and intersect the vertical axis in the point (0, 1 −π 0 (λ)), where λ = 1/2. The valuesπ LF C 0 (λ) and E{π rand 0 (λ)} are displayed above their respective graphs as pi0LFC and pi0rand, respectively. 
Discussion
In the context of simultaneous testing of composite null hypotheses, we have demonstrated that the usage of randomized p-values leads to a more accurate estimation π 0 when compared with the usage of LFC-based p-values. We have explicitly demonstrated this for the Schweder-Spjøtvoll estimator π 0 . The higher estimation variances induced by the uniform random variates used for randomization are in most cases negligible, so that the mean squared error is lower forπ rand 0 than forπ LF C 0 .
Our theory applies to any choice of the parameter γ = 2, . . . , s. We have not further discussed the choice of γ nor do we make recommendations in this work. Choosing γ close to s results in strong replicability statements, but potentially only few rejections. On the other hand, in the presence of a very large number of studies s, replicability statements may not be suitable when choosing γ = 2. Thus, one could make γ dependent on s, like γ = βs for β ∈ (0, 1). Alternatively, instead of pre-defining γ, we could for each j = 1, . . . , m determine the largest γ = γ(j), for which we would still reject H j . It is then possible to declare replicability for endpoint j if γ(j)/s > β holds, where β ∈ (0, 1) is pre-defined. Benjamini et al. (2009) gave a procedure that estimates a lower confidence bound γ max (j) on the number k = k(j) of studies in which endpoint j is a true bio-marker (j = 1, . . . , m). Under independence conditions the expected proportion of lower bounds γ(j) across all endpoints j ∈ {1, . . . , m}, that are indeed not larger than k(j), is then q.
Furthermore, we have not discussed the incorporation of the estimated proportion of true null hypotheses in so-called adaptive multiple tests. Blanchard and Roquain (2009) presented a categorization of adaptive procedures that divide between plug-in, two-stage and one-stage procedures, and provided adaptive procedures that control the false discovery rate. Finner and Gontscharuk (2009) investigated the problem of controlling the family-wise error rate when using an estimator of π 0 as a plug-in estimator in single-step or step-down procedures. Bogomolov and Heller (2018) gave an adaptive procedure that incorporates estimations of the proportion of true null hypotheses among the selected features and controls the false discovery rate for replicability analysis with two studies. It remains to be investigated to what extent the usage of randomized p-values can improve the power of such adaptive procedures. In the case of s = 1, some results in this direction can be found in Dickhaus (2013) . These results indicate, that the power gain can be substantial.
Finally, one challenging extension of our proposed methodology is to investigate randomized p-values for other types of summary statistics, in particular combination test statistics of Fisher-or Stouffer-Liptak-type; see, e. g., van Zwet and Oosterhoff (1967), Kim et al. (2013) and the references therein. In Appendix D we compare their (non-randomized) use inπ 0 with the use of our proposed randomized p-values that result from our summary statistics. Under the same model and considering the same parameter settings as in Section 5.2 the use of the randomized p-values in the Schweder-Spjøtvoll estimator is still more accurate in most cases. Another possibility in this direction is to consider statistics derived from Bayesian models, for instance local false discovery rates or Bayes factors, as in Yekutieli (2015) and Dickhaus (2015) , respectively.
for all x and parameters ϑ 1 , ϑ 2 ∈ Θ. Analogously, we denote T (ϑ 1 ) ≤ hr S (ϑ 2 ) , or T (ϑ 1 ) ≤ lr S (ϑ 2 ) , if F ϑ 1 , G ϑ 2 , f ϑ 1 , g ϑ 2 satisfy the corresponding requirements for parameters ϑ 1 , ϑ 2 ∈ Θ.
Appendix B. Some results regarding stochastic orders
We introduce some results regarding the hazard rate order. Let X 1 , . . . , X n , n ≥ 2, be independent, not necessarily identically distributed, random variables. We denote the corresponding order statistics of the first m ≤ n X i 's by X (1:m) ≤ · · · ≤ X (m:m) . For m = n we usually write X (1) ≤ · · · ≤ X (n) .
Theorem 5.
U k (k = 1, . . . , i). Since X 1 , . . . , X n were assumed to have i such X k , and prior calculations hold for any order of X 1 , . . . , X n , we can assume X k ≤ hr U k (k = 1, . . . , i) , as desired.
This lemma can be extended to any stochastically independent and identically distributed U 1 , . . . , U k with support (0, 1) or any support (a, b) shared with X 1 , . . . , X n .
The following theorem is due to (Shaked and Shanthikumar, 2007, Theorem 1.C.2) and establishes relationships between the three stochastic orders presented in Definition 2.
Theorem. For two continuous random variables
X, Y it holds X ≤ lr Y =⇒ X ≤ hr Y =⇒ X ≤ st Y .
Appendix C. Proofs
Proof of Theorem 1
In order to show the first assertion, we notice that, due to assumption (GA1), it holds {x ∈ Ω :
With respect to the second assertion, we obtain that
With that in mind, it results from (3), that
for all x ∈ Ω. Consequently, the numerator on the right hand side in (C.1) is either pr ϑ 0 {p LF C j (X) ≤ t} = t or pr ϑ 0 {θ j ∈ K j } for t < c j and t ≥ c j , respectively. This leads to
Finally, we show the third assertion. Using Part 2, we only have to show, thatθ j (x) ∈ K j implies p LF C j (x) ≤ c j for all x ∈ Ω, which is already part of (C.2).
Proof of Theorem 2
We recall from Theorem 1 that
Due to the stochastic independence between U j and X, we obtain for the first summand in (C.3), that 
is fulfilled. Note, that due to assumption (GA1) the term 1 K j {θ j (X)} on the left side in (C.4) can be omitted. The statement in Theorem 2 was that
is equivalent to the validity of p rand j . This follows from (C.4) when substituting z = t c j = t pr ϑ 0 (θ j ∈ K j ) and by seeing that pr ϑ p LF C j (X) ≤ t = pr ϑ T j (X) ∈ Γ j (t) , t ∈ [0, 1], holds, which follows from the inequalities in (3) and T j (X) having a continuous distribution under any parameter ϑ ∈ Θ.
Proof of Theorem 3
At first we show that
(C.5) holding for any ϑ ∈ Θ with θ j (ϑ) ∈ H j is equivalent to the validity of p rand j .
Let ϑ ∈ Θ with θ j (ϑ) ∈ H j be fixed. Using h ϑ from Lemma 1, the validity of p rand j is equivalent to h ϑ ≤ 0 for any such ϑ. With our condition to the rejection regions Γ j , it holds
and thus h ϑ (t) ≤ 0 for all t ∈ [0, 1] if and only if (C.5) holds. Furthermore, from assumption (GA1) it holds θ j ∈ K j = T j (X) ∈ Γ j (c j ) = T j (X) > F −1 (1 − c j ) =: a , which implies, that (C.5) is equivalent to
is equivalent to (C.7) holding for any a, and thus, it implies (C.5) and therefore the validity of p rand j .
Proof of Lemma 2
In order to verify (GA1), we make use of (RA2). It holds, that
For the verification of (GA2) (nested rejection regions), we see that for every j ∈ {1, . . . , m} and α ′ < α it holds
To see that (GA4) is fulfilled, let j ∈ {1, . . . , m} be fixed. We calculate the set of LFCs for ϕ j , i.e. the set of parameters ϑ ∈ Θ that yield the supremum in sup
and show that it does not depend on α.
, which is larger the smaller the p-values p 1,j (X), . . . , p s,j (X) are. For every i = 1, . . . , s, due to (RA4), there exist parameters ϑ i ∈ Θ, independent of α, such that p i,j (X) = 0 almost surely under ϑ j . Independently of α, this is satisfied for parameters with θ i,j (ϑ i ) large enough. It is clear, that for any LFC ϑ 0 ∈ Θ for ϕ j , it has to hold θ j (ϑ 0 ) ∈ H j and θ i,j (ϑ 0 ) large enough (without loss of generality equal to ∞) for γ − 1 indices i.
Without loss of generality, we consider a parameter ϑ 0 ∈ Θ with θ j (ϑ 0 ) ∈ H j and θ 1,j (ϑ 0 ) = · · · = θ γ−1,j (ϑ 0 ) = ∞, leaving θ i,j (ϑ 0 ) ≤ 0 for the remaining indices i = γ, . . . , s.
Due to assumption (RA4), the p-values p 1,j (X), . . . , p γ−1,j (X) are equal to zero and T j (X) = 1−p (γ),j (X) = max{1−p γ,j (X), . . . , 1−p s,j (X)} almost surely under ϑ 0 . We obtain that
Since the studies are independent, (C.8) is equal to
Now, using the relation in (4), the term in (C.9) equals
is maximized over the set of all ϑ 0 : θ i,j (ϑ 0 ) ≤ 0 (i = γ, . . . , s). Due to assumption (RA2), this is the case for any ϑ 0 ∈ Θ with θ i,j (ϑ 0 ) = 0 independently of α i,j (i = γ, . . . , s), such that pr ϑ 0 T j (X) ∈ Γ j (α) is being maximized by any parameter ϑ 0 with
Altogether, the set of LFCs for ϕ j is {ϑ ∈ Θ : θ j (ϑ) is any permutation of (∞, . . . , ∞ γ−1 , 0, . . . , 0
hence, obviously independent of α. Finally, we verify (GA3) as follows: For every j ∈ {1, . . . , m} and α ∈ (0, 1), it holds ∞, 0, . . . , 0) is an LFC for ϕ j . Furthermore, 1 − p i,j (X) is uniformly distributed on [0, 1] under an LFC ϑ 0 ∈ Θ with θ i,j (ϑ 0 ) = 0 (i = γ, . . . , s). Since max(U 1 , . . . , U k ) is Beta(s − γ + 1, 1)-distributed, for U 1 , . . . , U k , that are stochastically independent and identically, uniformly distributed on [0, 1], we obtain that (C.10) equals 1 − F Beta(s−γ+1,1) F −1
Beta(s−γ+1,1) (1 − α) = α, as desired.
Proof of Theorem 4
We want to show, that
holds for any parameters ϑ ∈ Θ with θ j (ϑ) ∈ H j and ϑ 0 an LFC for ϕ j . Let ϑ ∈ Θ with θ j (ϑ) ∈ H j , i.e. θ i,j (ϑ) ≤ 0 for at least s−γ +1 indices i, be given.
Since the distribution of T j (X) does not depend on the particular form of the LFC ϑ 0 , we choose one that fulfills θ i,j (ϑ) ≤ 0 = θ i,j (ϑ 0 ) for at least s − γ + 1 indices i. Without loss of generality, let θ i,j (ϑ) ≤ 0 (i = 1, . . . , s − γ + 1), and θ j (ϑ 0 ) = (0, . . . , 0
).
. Let F i,j be the cumulative distribution function of T i,j (X) under an LFC for ϕ i,j , i.e. under aθ ∈ Θ with θ i,j (θ) = 0. For i = 1, . . . , s − γ + 1, it holds θ i,j (ϑ 0 ) = 0, i.e. the parameter ϑ 0 is an LFC for ϕ i,j (i = 1, . . . ., s − γ + 1). From Part 3 in Theorem 5, it follows that
is uniformly distributed on [0, 1] (i = 1, . . . , s − u + 1). For ease of notation, we write P i = 1 − p i,j and T j (X) = 1 − p (γ),j (X) = P (s−γ+1) (X). Under ϑ 0 it then holds T j (X) and max{U 1 , . . . , U s−γ+1 } are identically distributed, since P s−γ+2 (X) = · · · = P s (X) = 1 almost surely due to (RA4), where U 1 , . . . , U s−γ+1 are stochastically independent and identically, uniformly distributed on [0, 1]. Now, (C.11) is equivalent to P (s−γ+1:n) (X) (ϑ) ≤ hr P (s−γ+1:s) (X) (ϑ 0 ) = U (s−γ+1:s−γ+1) , which follows directly from Lemma 3, since, from (C.12), it holds P i (X) (ϑ) ≤ hr U i for at least s − γ + 1 indices i ∈ {1, . . . , s}.
Appendix D. Further simulation results
The results of our Monte-Carlo simulation with regard to the standard deviations, cf. the end of Section 5.2, are listed in Table D.3 and Table D .4 for the utilization of the LFC-based and the randomized p-values, respectively. Furthermore, we looked at two different approaches for defining the LFCbased p-values. The test statistics T j (X) = 1 − p (γ),j do not regard the size of the s −γ larger p-values p (γ+1) , . . . , p (s) explicitly. Instead, one could consider
motivated by the Stouffer method and the Fisher method for combining pvalues, respectively, where Φ is the cumulative distribution function of the standard normal distribution in R, and F χ 2 2 (s−γ+1) is the cumulative distribution function of a χ 2 -distribution with 2 (s − γ + 1) degrees of freedom (Benjamini and Heller, 2008, Sec. 2.2) . Instead of only considering p (γ),j like in our model setup, T (S) j and T (F ) j also look at the evidence against a rejection from the s − γ bigger p-values. Benjamini and Heller (2008) showed that applying the Benjamini-Hochberg linear step up test from Benjamini and Hochberg (1995) on the LFC-based p-values p LF C 1 , . . . , p LF C m controls the false discovery rate even if the p-values within each study admit a positive dependence. For more details see Theorem 3 in Benjamini and Heller (2008) .
Models based on these test statistics, however, do not fulfill assumption (GA1) from Section 2, such that Theorem 1 does not apply, and calculating the randomized p-values p rand 1 , . . . , p rand m as in Definition 1 becomes more difficult.
We simulated the expected values of the estimatorπ 0 (1/2) when utilizing the LFC-based p-values under these alternative test statistics. The results of the Monte-Carlo simulations with 10, 000 repetitions can be found in Table D.5 for the Stouffer-based and Table D .6 for the Fisher-based p-values. More accurate estimations as compared toπ rand 0 are written in bold. Compared to the expected values when utilizing our randomized p-values (p rand j ) j both alternatives only perform better in case of µ min = 0 and lower γ (2, 4, 6 for Stouffer, and 2, 4 for Fisher). Table D .3: Empirical standard deviations forπ 0 (1/2) using (p LF C j ) j=1,...,m in Model 1 with s = 10, resulting from a Monte-Carlo simulation with 10, 000 repetitions γ = 2 π 0 0.6 0.7 0.8 0.9 (µ min , µmax) (0,2) 0.07582752 0.08296189 0.08786311 0.09318406 (-0.5,3) 0.0695563 0.07470407 0.0808962 0.08561848 (-1,4) 0.06144261 0.06616704 0.07076652 0.07451185 (-1.5,5) 0.05453308 0.05847278 0.06289423 0.06657209 γ = 4 π 0 0.6 0.7 0.8 0.9 (µ min , µmax) (0,2) 0.06851676 0.07402335 0.07861075 0.084044 (-0.5,3) 0.05976733 0.06390461 0.06858124 0.07387649 (-1,4) 0.0512543 0.05480785 0.05943488 0.06301813 (-1.5,5) 0.04496894 0.04844289 0.05183053 0.05536219 γ = 6 π 0 0.6 0.7 0.8 0.9 (µ min , µmax) (0,2) 0.06060406 0.06547952 0.06891937 0.0742553 (-0.5,3) 0.05168182 0.05610461 0.05966287 0.06261066 (-1,4) 0.04385788 0.04703952 0.05022082 0.05353003 (-1.5,5) 0.03789674 0.04156683 0.04366071 0.04636814 γ = 8 π 0 0.6 0.7 0.8 0.9 (µ min , µmax) (0,2) 0.06101877 0.06274993 0.06467866 0.06596085 (-0.5,3) 0.05000569 0.05270983 0.05467924 0.05597926 (-1,4) 0.04252793 0.04467561 0.04602834 0.04805289 (-1.5,5) 0.03655808 0.0375914 0.03910888 0.04120146 γ = 10 π 0 0.6 0.7 0.8 0.9 (µ min , µmax) (0,2) 0.07542883 0.07593555 0.07524137 0.07511923 (-0.5,3) 0.06533901 0.06485274 0.06546255 0.064975 (-1,4) 0.05600993 0.05558931 0.05601106 0.05565804 (-1.5,5) 0.0484561 0.04821363 0.04870596 0.04752345 Table D .4: Empirical standard deviations forπ 0 (1/2) using (p rand j ) j=1,...,m in Model 1 with s = 10, resulting from a Monte-Carlo simulation with 10, 000 repetitions γ = 2 π 0 0.6 0.7 0.8 0.9 (µ min , µmax) (0,2) 0.07581577 0.08296278 0.08805736 0.09328741 (-0.5,3) 0.0702544 0.07536504 0.08154187 0.08638383 (-1,4) 0.06395161 0.06911728 0.07406993 0.07819693 (-1.5,5) 0.06221166 0.06620503 0.07202633 0.07624616 γ = 4 π 0 0.6 0.7 0.8 0.9 (µ min , µmax) (0,2) 0.06958866 0.07479425 0.07966822 0.08502931 (-0.5,3) 0.06402867 0.06926745 0.07450052 0.07952569 (-1,4) 0.0627167 0.06769249 0.07350674 0.07756825 (-1.5,5) 0.06598907 0.07154958 0.07621329 0.08084872 γ = 6 π 0 0.6 0.7 0.8 0.9 (µ min , µmax) (0,2) 0.06774445 0.07290022 0.07769824 0.0821969 (-0.5,3) 0.06669294 0.07219919 0.077621 0.08185157 (-1,4) 0.07012927 0.07496831 0.08007004 0.08618822 (-1.5,5) 0.07328739 0.07785646 0.08384216 0.08907628 γ = 8 π 0 0.6 0.7 0.8 0.9 (µ min , µmax) (0,2) 0.07937488 0.08193387 0.0860587 0.0897265 (-0.5,3) 0.0774249 0.08324976 0.08713005 0.09173463 (-1,4) 0.07788223 0.08412603 0.08823772 0.09349471 (-1.5,5) 0.07831725 0.0835687 0.08916617 0.09328771 γ = 10 π 0 0.6 0.7 0.8 0.9 (µ min , µmax) (0,2) 0.09869885 0.09828208 0.09745444 0.09849114 (-0.5,3) 0.09665863 0.09552648 0.0971173 0.09756151 (-1,4) 0.09492729 0.09507453 0.09681341 0.09597547 (-1.5,5) 0.09626054 0.09466757 0.09469119 0.09489155 
